DermTech, Inc. (DMTK): Price and Financial Metrics

DermTech, Inc. (DMTK): $0.42

0.07 (+18.31%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

DMTK Price/Volume Stats

Current price $0.42 52-week high $3.90
Prev. close $0.36 52-week low $0.31
Day low $0.31 Volume 15,126,796
Day high $0.49 Avg. volume 475,445
50-day MA $0.62 Dividend yield N/A
200-day MA $1.31 Market Cap 14.68M

DMTK Stock Price Chart Interactive Chart >


DermTech, Inc. (DMTK) Company Bio


DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.


DMTK Latest News Stream


Event/Time News Detail
Loading, please wait...

DMTK Latest Social Stream


Loading social stream, please wait...

View Full DMTK Social Stream

Latest DMTK News From Around the Web

Below are the latest news stories about DERMTECH INC that investors may wish to consider to help them evaluate DMTK as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to dive into the biggest pre-market stock movers for Friday with all the shares investors will want to keep an eye on today!

William White on InvestorPlace | November 3, 2023

DermTech, Inc. (NASDAQ:DMTK) Q3 2023 Earnings Call Transcript

DermTech, Inc. (NASDAQ:DMTK) Q3 2023 Earnings Call Transcript November 2, 2023 DermTech, Inc. beats earnings expectations. Reported EPS is $-0.57, expectations were $-0.68. Operator: Ladies and gentlemen, thank you for standing by. Welcome to DermTech’s Third Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, […]

Yahoo | November 3, 2023

DermTech Inc (DMTK) Reports 10% Increase in Total Revenue for Q3 2023

ASP for DermTech Melanoma Test Rises by 24% Year-Over-Year

Yahoo | November 2, 2023

DermTech Reports Third-Quarter 2023 Financial Results

SAN DIEGO, November 02, 2023--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its third-quarter 2023 financial results.

Yahoo | November 2, 2023

DermTech Announces Release Date for Third-Quarter 2023 Financial Results

SAN DIEGO, October 12, 2023--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, will host a conference call and webcast on Thursday, November 2, 2023 at 5:00 p.m. Eastern Time (ET) to discuss the Company's third-quarter 2023 operating and financial results. In advance of the call on November 2, 2023, DermTech will issue its third-quarter 2023 earnings press release.

Yahoo | October 12, 2023

Read More 'DMTK' Stories Here

DMTK Price Returns

1-mo -29.49%
3-mo -67.69%
6-mo -72.55%
1-year -83.27%
3-year -98.85%
5-year N/A
YTD -76.00%
2023 -1.13%
2022 -88.80%
2021 -51.29%
2020 161.61%
2019 -39.28%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!